Sign in

CIK 0001711279 · Large accelerated filer

Krystal Biotech, Inc.

Sign in to watch
Ticker
KRYS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
821080209
Phone
(412) 586-5830
Business address
2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$17,966,069
in 2 filings, $18.0M under 10b5-1 plans

Net −$17,966,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-09-11 Krishnan Suma President, R&D Sale 10b5-1 −2,110 $129.10 $272K 1,599,206
2023-09-11 Krishnan Suma President, R&D Sale 10b5-1 −5,008 $125.23 $627K 1,679,330
2023-09-11 Krishnan Suma President, R&D Sale 10b5-1 −5,452 $126.17 $688K 1,673,878
2023-09-11 Krishnan Suma President, R&D Sale 10b5-1 −1,873 $127.18 $238K 1,672,005
2023-09-11 Krishnan Suma President, R&D Sale 10b5-1 −10,557 $128.37 $1.4M 1,661,448
2023-09-11 Krishnan Suma President, R&D Sale 10b5-1 −2,110 $129.10 $272K 1,659,338
2023-09-11 Krishnan Krish S President and CEO Sale 10b5-1 −5,008 $125.23 $627K 1,679,330
2023-09-11 Krishnan Krish S President and CEO Sale 10b5-1 −5,452 $126.17 $688K 1,673,878
2023-09-11 Krishnan Krish S President and CEO Sale 10b5-1 −1,873 $127.18 $238K 1,672,005
2023-09-11 Krishnan Krish S President and CEO Sale 10b5-1 −10,557 $128.37 $1.4M 1,661,448
2023-09-11 Krishnan Krish S President and CEO Sale 10b5-1 −2,110 $129.10 $272K 1,659,338
2023-09-11 Krishnan Krish S President and CEO Sale 10b5-1 −5,007 $125.23 $627K 1,619,199
2023-09-11 Krishnan Krish S President and CEO Sale 10b5-1 −5,452 $126.17 $688K 1,613,747
2023-09-11 Krishnan Krish S President and CEO Sale 10b5-1 −1,874 $127.18 $238K 1,611,873
2023-09-11 Krishnan Krish S President and CEO Sale 10b5-1 −10,557 $128.37 $1.4M 1,601,316
2023-09-11 Krishnan Krish S President and CEO Sale 10b5-1 −2,110 $129.10 $272K 1,599,206
2023-06-30 Mazzacco Catherine Director Grant or award · Stock Option (Right to Buy) +2,180 2,180
2023-06-30 Sutherland Everett Rand Director Grant or award · Stock Option (Right to Buy) +6,800 6,800
2023-06-30 ROSSI DINO A Director Grant or award · Stock Option (Right to Buy) +6,800 6,800
2023-06-30 Mason Christopher Director Grant or award · Stock Option (Right to Buy) +6,800 6,800

Page 28 of 42 · 828 trades